Effect of on-treatment dose adjustments on the efficacy of enfortumab vedotin and pembrolizumab (EVP) in advanced urothelial carcinoma (aUC): A UNITE analysis.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jeffrey Yinhong Zhong, Albert Jang, Tanya Jindal, Cindy Y. Jiang, Zachariah Thomas, Eugene Oh, Charles B. Nguyen, Dimitra Bakaloudi, Salvador Jaime-Casas, Abhishek Tripathi, Petros Grivas, Irene Tsung, Matthew T. Campbell, Omar Alhalabi, Melissa A. Reimers, Ali Raza Khaki, Zhengyi Chen, Pingfu Fu, Vadim S. Koshkin, Jason Robert Brown
Institutions: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Mayo Clinic, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, University of Michigan, City Of Hope National Medical Center, University of Washington, Fred Hutch Cancer Center, Washington University in St. Louis, Stanford University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162547041
Cites:
Cited by:
Related to: